Levofloxacin 500mgTablet
Antibiotics

Levofloxacin 500mg

Levofloxacin

Optically pure L-isomer of ofloxacin with enhanced gram-positive activity — particularly against Streptococcus pneumoniae — that makes it the preferred fluoroquinolone for community-acquired pneumonia, acute bacterial sinusitis, and chronic bacterial prostatitis under major international respiratory guidelines. Its once-daily dosing and availability in IV and oral formulations with equivalent bioavailability facilitates seamless step-down therapy. Cipla and Glenmark manufacture 250mg, 500mg, and 750mg tablets exported to hospital and primary care markets globally.

Strengths

250mg / 500mg / 750mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Levofloxacin 250mg / 500mg / 750mg
Dosage Form
Tablet
Available Strengths
250mg / 500mg / 750mg
Packing
10 tablets/strip
Route of Administration
Oral, with or without food
Dosage
250-750mg once daily for 5-14 days depending on infection
Indications
Community-acquired pneumonia, complicated and uncomplicated UTI, acute bacterial sinusitis, chronic bacterial prostatitis, plague
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 25°C
Shelf Life
36 months
Side Effects
Nausea, headache, diarrhea, insomnia, dizziness, constipation
Precautions
Same black box warnings as ciprofloxacin; risk of hypoglycemia with antidiabetic agents; CNS effects; QT prolongation

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Azithromycin 500mgTablet

Azithromycin 500mg

Azithromycin

Azalide subclass macrolide antibiotic that achieves exceptionally high and sustained intracellular tissue concentrations — up to 100-fold higher than plasma levels — enabling short 3-day or 5-day treatment courses for respiratory, skin, and sexually transmitted bacterial infections. Its anti-inflammatory properties beyond direct bacteriostasis provide additional clinical benefit in community-acquired pneumonia. Cipla and Alkem Labs manufacture 250mg and 500mg tablets exported globally as a staple of primary care antibiotic formularies.

250mg / 500mg
Amoxicillin 500mgCapsule

Amoxicillin 500mg

Amoxicillin Trihydrate

Aminopenicillin with extended gram-positive and gram-negative bactericidal activity, offering superior oral bioavailability (~90%) compared to ampicillin and the convenience of twice- or thrice-daily dosing for common community infections of the respiratory tract, urinary tract, skin, and ear. It is also a key component of H. pylori triple-eradication therapy and is a WHO Essential Medicine available in both capsule and dispersible tablet forms. Cipla and GSK manufacture 250mg and 500mg capsules exported to primary care markets globally.

250mg / 500mg
Augmentin 625mgTablet

Augmentin 625mg

Amoxicillin + Clavulanate

Fixed-dose combination of amoxicillin with clavulanic acid, a potent beta-lactamase inhibitor that protects amoxicillin from enzymatic degradation and restores its activity against beta-lactamase-producing strains of Staphylococcus, Haemophilus, Moraxella, and Klebsiella commonly encountered in community and hospital settings. Widely prescribed for sinusitis, otitis media, lower respiratory infections, UTIs, animal bites, and dental abscesses resistant to amoxicillin alone. GSK and Cipla supply 625mg and 1g tablets exported as a primary care antibiotic staple worldwide.

625mg / 1g

Need bulk pricing for Levofloxacin 500mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote